WASHINGTON : Enhanced tariffs on pharma imports in the US can severely impact Indian drug manufacturers as it would lead to higher production costs, making shipments less competitive against products from other countries.
Smaller drug firms operating on thin margins can face severe pressure potentially forcing consolidation or closure.
The automobile sector, on the other hand, is expected to have a very minimal impact owing to the US being a small export market.
Terming India as a very high tariff nation, US President Donald Trump has said . . .
Disclaimer: This information has been collected through secondary research and Daily Shipping Times is not responsible for any errors in the same.
You cannot copy content of this page
